Phase II Study of the Trifunctional Antibody Catumaxomab Administered Intra- and Postoperatively in Patients With Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Ovarian Cancer
Related studies linked through entity extraction aliases.
Autologous T Cells With or Without Cyclophosphamide and Fludarabine in Treating Patients With Recurrent or Persistent Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer (Fludarabine Treatment Closed as of 12/01/2009)
- Status
- COMPLETED
- Phase
- PHASE1
Doxorubicin and Carboplatin in Treating Patients With Recurrent Ovarian Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Safety Study of a Genetically Modified Adenovirus in Ovarian Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE1
Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Gemcitabine, Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Progressive or Relapsed Metastatic Germ Cell Tumors
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Combination Chemotherapy and Autologous Peripheral Stem Cell Transplant in Treating Patients With Stage III, Stage IV, or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Conformal Radiation Therapy in Treating Patients With Metastatic Cancer Outside the Brain
- Status
- TERMINATED
- Phase
- PHASE2
Safety Study Of Avastin And Pelvic Radiation In Women With Recurrent Gynecological Cancers
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Evaluate the Safety, Tolerability, and Activity of Lonafarnib and Docetaxel (Study P04467AM1)(TERMINATED)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Use of CA125 and Complementary Biomarkers for the Early Detection of Ovarian Cancer in Low Risk Women
- Status
- RECRUITING
- Phase
- NA
Effect of Serotonin Level on Constipation Caused by Chemotherapy in Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
- Status
- TERMINATED
- Phase
- N/A
Hydralazine Valproate for Ovarian Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
An RCT of Concurrent and Maintenance Cediranib in Women With Platinum-sensitive Relapsed Ovarian Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
NYU Ovarian Cancer Early Detection Program Blood and Genetics
- Status
- TERMINATED
- Phase
- N/A
Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors, Multiple Myeloma, or Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Adjuvant Whole Abdominal Intensity Modulated Radiotherapy (IMRT) for High Risk Stage FIGO III Patients With Ovarian Cancer
- Status
- UNKNOWN
- Phase
- PHASE1
Sorafenib + Topotecan for Platinum-Resistant Recurrent Ovarian Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Phase I Study of ABT-888 in Combination With Temozolomide in Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE1
BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE2